Showing 1 - 5 results of 5 for search 'Amelie deGregorio', query time: 0.03s Refine Results
  1. 1
    Coincidence of Intra-Abdominal Splenosis in a Patient with Advanced Ovarian Cancer: Case Report and Review of the Literature

    Coincidence of Intra-Abdominal Splenosis in a Patient with Advanced Ovarian Cancer: Case Report and Review of the Literature by Tatjana Braun, Amelie De Gregorio, Lisa Baumann, Jochen Steinacker, Wolfgang Janni, Nikolaus De Gregorio

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions

    Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions by Fabienne Schochter, Thomas W. P. Friedl, Amelie deGregorio, Sabrina Krause, Jens Huober, Brigitte Rack, Wolfgang Janni

    Published 2019-11-01
    Get full text
    Article
  3. 3
    BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients

    BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients by Manfred Wischnewsky, Lukas Schwentner, Joachim Diessner, Amelie de Gregorio, Ralf Joukhadar, Dayan Davut, Jessica Salmen, Inga Bekes, Matthias Kiesel, Max Müller-Reiter, Maria Blettner, Regine Wolters, Wolfgang Janni, Rolf Kreienberg, Achim Wöckel, Florian Ebner

    Published 2021-06-01
    Get full text
    Article
  4. 4
    Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial

    Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial by Elisabeth K. Trapp, Peter A. Fasching, Tanja Fehm, Andreas Schneeweiss, Volkmar Mueller, Nadia Harbeck, Ralf Lorenz, Claudia Schumacher, Georg Heinrich, Fabienne Schochter, Amelie de Gregorio, Marie Tzschaschel, Brigitte Rack, Wolfgang Janni, Thomas W. P. Friedl

    Published 2022-08-01
    Get full text
    Article
  5. 5
    Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial

    Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial by Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni

    Published 2020-10-01
    Get full text
    Article

Search Tools: